214 related articles for article (PubMed ID: 24667078)
21. Combination oral antiplatelet therapy may increase the risk of hemorrhagic complications in patients with acute ischemic stroke caused by large artery disease.
Itabashi R; Mori E; Furui E; Sato S; Yazawa Y; Fujiwara S
Thromb Res; 2011 Dec; 128(6):541-6. PubMed ID: 21741075
[TBL] [Abstract][Full Text] [Related]
22. A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons.
Brown DG; Wilkerson EC; Love WE
J Am Acad Dermatol; 2015 Mar; 72(3):524-34. PubMed ID: 25486915
[TBL] [Abstract][Full Text] [Related]
23. Complications after placement of an intracoronary stent: nursing implications.
Dabbs AD; Chambers CE; Macauley K
Am J Crit Care; 1998 Mar; 7(2):117-22. PubMed ID: 9509225
[TBL] [Abstract][Full Text] [Related]
24. Bleeding complications following peripheral regional anaesthesia in patients treated with anticoagulants or antiplatelet agents: A systematic review.
Joubert F; Gillois P; Bouaziz H; Marret E; Iohom G; Albaladejo P
Anaesth Crit Care Pain Med; 2019 Oct; 38(5):507-516. PubMed ID: 30586601
[TBL] [Abstract][Full Text] [Related]
25. Delays in recognition and management of giant cell arteritis: results from a retrospective audit.
Ezeonyeji AN; Borg FA; Dasgupta B
Clin Rheumatol; 2011 Feb; 30(2):259-62. PubMed ID: 21086005
[TBL] [Abstract][Full Text] [Related]
26. Safety of new oral anticoagulants with dual antiplatelet therapy in patients with acute coronary syndromes.
Tsu LV; Dager WE
Ann Pharmacother; 2013 Apr; 47(4):573-7. PubMed ID: 23548645
[TBL] [Abstract][Full Text] [Related]
27. Treatment of corticosteroid-resistant giant cell arteritis.
Wilke WS; Hoffman GS
Rheum Dis Clin North Am; 1995 Feb; 21(1):59-71. PubMed ID: 7732174
[TBL] [Abstract][Full Text] [Related]
28. High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition.
Berger CT; Wolbers M; Meyer P; Daikeler T; Hess C
Rheumatology (Oxford); 2009 Mar; 48(3):258-61. PubMed ID: 19129348
[TBL] [Abstract][Full Text] [Related]
29. Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy.
Manchikanti L; Falco FJ; Benyamin RM; Caraway DL; Kaye AD; Helm S; Wargo BW; Hansen H; Parr AT; Singh V; Swicegood JR; Smith HS; Schultz DM; Malla Y; Hirsch JA
Pain Physician; 2013 Apr; 16(2 Suppl):SE261-318. PubMed ID: 23615893
[TBL] [Abstract][Full Text] [Related]
30. Giant cell (temporal) arteritis.
Caselli RJ; Hunder GG
Neurol Clin; 1997 Nov; 15(4):893-902. PubMed ID: 9367971
[TBL] [Abstract][Full Text] [Related]
31. Bleeding following rattlesnake envenomation in patients with preenvenomation use of antiplatelet or anticoagulant medications.
Levine M; Ruha AM; Padilla-Jones A; Gerkin R; Thomas SH
Acad Emerg Med; 2014 Mar; 21(3):301-7. PubMed ID: 24628755
[TBL] [Abstract][Full Text] [Related]
32. Quality of life of patients treated for giant cell arteritis: a case-control study.
Jobard S; Magnant J; Blasco H; Ferreira-Maldent N; Griffoul I; Diot E; Maillot F
Clin Rheumatol; 2017 Sep; 36(9):2055-2062. PubMed ID: 28405843
[TBL] [Abstract][Full Text] [Related]
33. Antiplatelet therapy and anticoagulation in patients with hypertension.
Griffin G
Am Fam Physician; 2005 Mar; 71(5):897-9. PubMed ID: 15768617
[TBL] [Abstract][Full Text] [Related]
34. Maintenance of perioperative antiplatelet and anticoagulant therapy for vitreoretinal surgery.
Ryan A; Saad T; Kirwan C; Keegan DJ; Acheson RW
Clin Exp Ophthalmol; 2013; 41(4):387-95. PubMed ID: 23094982
[TBL] [Abstract][Full Text] [Related]
35. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
Hermosillo AJ; Spinler SA
Ann Pharmacother; 2008 Jun; 42(6):790-805. PubMed ID: 18477734
[TBL] [Abstract][Full Text] [Related]
36. Investigational drugs for the treatment of acute myocardial infarction: focus on antiplatelet and anticoagulant agents.
Yandrapalli S; Andries G; Gupta S; Dajani AR; Aronow WS
Expert Opin Investig Drugs; 2019 Mar; 28(3):223-234. PubMed ID: 30580647
[TBL] [Abstract][Full Text] [Related]
37. The Association Between Giant Cell Arteritis and Ischemic Heart Disease: A Population Based Cross-Sectional Study.
Dagan A; Mahroum N; Segal G; Tiosano S; Watad A; Comaneshter D; Cohen AD; Amital H
Isr Med Assoc J; 2017 Jul; 19(7):411-414. PubMed ID: 28786254
[TBL] [Abstract][Full Text] [Related]
38. [Cardiovascular diseases, antiplatelet agents, anticoagulants and hemorrhagic risk].
Eusébio J; Reny JL; Fontana P; Nendaz M
Rev Med Suisse; 2010 Oct; 6(267):1942, 1944-6, 1948-50. PubMed ID: 21125726
[TBL] [Abstract][Full Text] [Related]
39. Risk of hemorrhage associated with co-prescriptions for Ginkgo biloba and antiplatelet or anticoagulant drugs.
Chan AL; Leung HW; Wu JW; Chien TW
J Altern Complement Med; 2011 Jun; 17(6):513-7. PubMed ID: 21649517
[TBL] [Abstract][Full Text] [Related]
40. Clinical Outcomes Associated With the Use of Anticoagulant and Antiplatelet Agents in Patients Undergoing Treatment for Infective Endocarditis: A Pilot Study.
Pathickal SM; Park TE; Sharma R
Clin Ther; 2020 Sep; 42(9):1828-1838. PubMed ID: 32758375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
